Induction of ovulation in infertile women with hyperandrogenism and insulin resistance

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 6, 2000, Pages 1412-1418

  Barbieri, Robert L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

HAIR AN syndrome; Hyperandrogenism; Insulin resistance; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; CLOMIFENE; FOLLITROPIN; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; METFORMIN; PIOGLITAZONE; PRASTERONE SULFATE; ROSIGLITAZONE; TESTOSTERONE; TROGLITAZONE;

ANDROGEN METABOLISM; ARTICLE; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; HORMONAL THERAPY; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0034521558     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107627     Document Type: Article

References (25)

1. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
2. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovary disease: Indirect evidence for partial gonadotroph desensitization
3. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women
4. Hyperandrogenism, insulin resistance and acantbosis nigricans syndrome. A common endocrinopathy with distinct pathophysiologic features
5. Some genetic syndromes associated with hyperandrogenism
6. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
7. Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate
8. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
9. Effect of body weight reduction on plasma androgens in obese infertile women
10. Clinical and hormonal characteristics of obese and amenorrheic women before and after weight loss
11. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment
12. Effects of weight loss on the hormonal profile in obese infertile women
13. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women
14. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women
15. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome
16. The management of non-insulin dependent diabetes during pregnancy
17. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome
18. Administration of metformin to a diabetic woman with extreme hyperandrogenemia of nontumoral origin: Management of infertility and prevention of inadvertent masculinization of a female fetus
19. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
20. Effects of metformin on gonadotropin induced ovulation in women with polycystic ovary syndrome
21. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome
22. The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
23. Pregnancy after treatment with the insulin-sensitizing agent troglitazone in an obese woman with the hyperandrogenic, insulin-resistant acanthosis nigricans syndrome
24. High ovulatory rates with use of troglitazone in clomiphene resistant women with polycystic ovary syndrome
25. Troglitazone induced hepatic failure leading to liver transplantation